This product is antibody S227.14 that recognizes SARS-CoV. The antibody S227.14 immunoassay techniques such as: ELISA, RIA.
Figure 1 Mapping of neutralizing epitopes on the SARS-CoV S glycoprotein recognized by human MAbs through sequence analysis and cross-competition studies.
Cross-competition of MAbs binding to the SARS-CoV S glycoprotein. Shown are the percentages of inhibition of the binding of 3 biotinylated MAbs (S109.8, S227.14, and S230.15; concentration, 0.1 μg/ml) to the recombinant SARS-CoV S glycoprotein by a panel of 23 unlabeled competing MAbs (at a saturating concentration [5 μg/ml]) belonging to groups I through VI.
Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008). Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. Journal of virology, 82(7), 3220-3235.
Figure 2 Prophylactic treatment of lethal SARS-CoV infections in 10-week-old BALB/c mice with 25 μg of cross-neutralizing MAbs.
Body weights of mice infected with MA15 were measured daily after passive transfer of 25 μg of MAb S109.8 (+), S227.14 (○), S230.15 (×), or D2.2 (□).
Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008). Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge. Journal of virology, 82(7), 3220-3235.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-885-S(P) | Recombinant Anti-SARS-CoV Antibody scFv Fragment | RIA, ELISA, FuncS | scFv |
MHH-885-S(P) | Recombinant Human Anti-SARS-CoV Antibody scFv Fragment | Neut, IF, FuncS | scFv |
HPAB-0102LY-S(P) | Anti-SARS-CoV Antibody scFv Fragment (S227.14) | ELISA, RIA | scFv |
HPAB-1909-FY-F(E) | Human Anti-SARS-CoV Recombinant Antibody (clone 03-001); scFv Fragment | ELISA | Human scFv |
HPAB-2049-FY-S(P) | Human Anti-SARS-CoV Recombinant Antibody (clone CR03-022); scFv Fragment | Neut, ELISA, FC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-649LC | Mouse Anti-SARS-CoV Recombinant Antibody (MRO-649LC) | ELISA | Mouse antibody |
MRO-650LC | Mouse Anti-SARS-CoV Recombinant Antibody (MRO-650LC) | ELISA | Mouse antibody |
MRO-651LC | Mouse Anti-SARS-CoV Recombinant Antibody (MRO-651LC) | ELISA | Mouse antibody |
MRO-652LC | Mouse Anti-SARS-CoV Recombinant Antibody (MRO-652LC) | ELISA | Mouse antibody |
MRO-649LC-S(P) | Mouse Anti-SARS-CoV Recombinant Antibody; scFv Fragment (MRO-649LC-S(P)) | ELISA | Mouse scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0297CQ | Recombinant Human Anti-SARS-CoV Antibody (HuMAb 03-014) | ELISA, FC, Neut | Human IgG1 |
HPAB-1909-FY | Human Anti-SARS-CoV Recombinant Antibody (clone 03-001) | ELISA | Human IgG |
HPAB-1910-FY | Human Anti-SARS-CoV Recombinant Antibody (clone 03-002) | ELISA | Human IgG |
HPAB-1911-FY | Human Anti-SARS-CoV Recombinant Antibody (clone 03-009) | ELISA, IF, EM | Human IgG |
HPAB-1912-FY | Human Anti-SARS-CoV Recombinant Antibody (clone 03-018) | ELISA, IF, EM, Inhib | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1909-FY-S(P) | Human Anti-SARS-CoV Recombinant Antibody (clone 03-001); Fab Fragment | ELISA | Human Fab |
HPAB-1910-FY-S(P) | Human Anti-SARS-CoV Recombinant Antibody (clone 03-002); Fab Fragment | ELISA | Human Fab |
HPAB-1911-FY-S(P) | Human Anti-SARS-CoV Recombinant Antibody (clone 03-009); Fab Fragment | ELISA | Human Fab |
HPAB-1912-FY-S(P) | Human Anti-SARS-CoV Recombinant Antibody (clone 03-018); Fab Fragment | ELISA | Human Fab |
HPAB-1913-FY-S(P) | Human Anti-SARS-CoV Recombinant Antibody (clone G1); Fab Fragment | ELISA, IF, IHC | Humanized Fab |
There are currently no Customer reviews or questions for HPAB-0102LY. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.